You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Drug Repurposing Market Research Report 2021 Professional Edition

Market Analysis and Insights: Global Drug Repurposing Market
The research report studies the Drug Repurposing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Drug Repurposing market size is projected to reach US$ 30920 million by 2027, from US$ 24570 million in 2020, at a CAGR of 2.9% during 2021-2027.
Global Drug Repurposing Scope and Segment
The global Drug Repurposing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repurposing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
by Application, this report covers the following segments
Hospitals
Ambulatory Surgical Centers
Others
Global Drug Repurposing market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Drug Repurposing key players in this market include:
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
1 Market Overview of Drug Repurposing
1.1 Drug Repurposing Market Overview
1.1.1 Drug Repurposing Product Scope
1.1.2 Drug Repurposing Market Status and Outlook
1.2 Global Drug Repurposing Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Drug Repurposing Market Size by Region (2016-2027)
1.4 Global Drug Repurposing Historic Market Size by Region (2016-2021)
1.5 Global Drug Repurposing Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Drug Repurposing Market Size (2016-2027)
1.6.1 North America Drug Repurposing Market Size (2016-2027)
1.6.2 Europe Drug Repurposing Market Size (2016-2027)
1.6.3 Asia-Pacific Drug Repurposing Market Size (2016-2027)
1.6.4 Latin America Drug Repurposing Market Size (2016-2027)
1.6.5 Middle East & Africa Drug Repurposing Market Size (2016-2027)

2 Drug Repurposing Market Overview by Type
2.1 Global Drug Repurposing Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Drug Repurposing Historic Market Size by Type (2016-2021)
2.3 Global Drug Repurposing Forecasted Market Size by Type (2022-2027)
2.4 Oncology
2.5 CNS Diseases
2.6 Neurodegenerative Diseases
2.7 Others

3 Drug Repurposing Market Overview by Application
3.1 Global Drug Repurposing Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Drug Repurposing Historic Market Size by Application (2016-2021)
3.3 Global Drug Repurposing Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Ambulatory Surgical Centers
3.6 Others

4 Drug Repurposing Competition Analysis by Players
4.1 Global Drug Repurposing Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Repurposing as of 2020)
4.3 Date of Key Players Enter into Drug Repurposing Market
4.4 Global Top Players Drug Repurposing Headquarters and Area Served
4.5 Key Players Drug Repurposing Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Repurposing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Astellas Pharma
5.1.1 Astellas Pharma Profile
5.1.2 Astellas Pharma Main Business
5.1.3 Astellas Pharma Drug Repurposing Products, Services and Solutions
5.1.4 Astellas Pharma Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.1.5 Astellas Pharma Recent Developments
5.2 Biovista
5.2.1 Biovista Profile
5.2.2 Biovista Main Business
5.2.3 Biovista Drug Repurposing Products, Services and Solutions
5.2.4 Biovista Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.2.5 Biovista Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Drug Repurposing Products, Services and Solutions
5.3.4 Novartis Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.3.5 AbbVie Recent Developments
5.4 AbbVie
5.4.1 AbbVie Profile
5.4.2 AbbVie Main Business
5.4.3 AbbVie Drug Repurposing Products, Services and Solutions
5.4.4 AbbVie Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.4.5 AbbVie Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Drug Repurposing Products, Services and Solutions
5.5.4 Pfizer Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.5.5 Pfizer Recent Developments
5.6 Allergan
5.6.1 Allergan Profile
5.6.2 Allergan Main Business
5.6.3 Allergan Drug Repurposing Products, Services and Solutions
5.6.4 Allergan Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.6.5 Allergan Recent Developments
5.7 NuMedii
5.7.1 NuMedii Profile
5.7.2 NuMedii Main Business
5.7.3 NuMedii Drug Repurposing Products, Services and Solutions
5.7.4 NuMedii Drug Repurposing Revenue (US$ Million) & (2016-2021)
5.7.5 NuMedii Recent Developments

6 North America
6.1 North America Drug Repurposing Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Drug Repurposing Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Drug Repurposing Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Drug Repurposing Market Dynamics
11.1 Drug Repurposing Industry Trends
11.2 Drug Repurposing Market Drivers
11.3 Drug Repurposing Market Challenges
11.4 Drug Repurposing Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140